"People are dying": diabetics rate insulin against the backdrop of rising drug prices

Drug manufacturers have been cooked on Wednesday for a steep rise in insulin prices, which doubled in the past ninety years and led some patients to a life-saving diet. One study found that by 2030 insulin deficiency could affect nearly 40 million people with diabetes.

"No one cared or nobody understood that without this next insulin vial I would not have seen another week," said Kristen Whitney Daniels, 28,

She began to rate her insulin after being expelled from her parents' insurance plan two years ago.

"I can not explain how to isolate and how scary," she said. a patient at the Center for Diabetes at Yale University, where a recent study by the American Medical Association magazine found that one in four patients reported "lack of costs." Dr. Kasa Lipskaya treats patients in the clinic and is the main author of the study. She testified on the Capitol Hill last week.

"This bottle of insulin was worth only $ 21

when it first appeared on the market in 1996. Now it costs $ 275," she said. . On Wednesday, Sanofi announced that it would lower insulin prices for uninsured patients and those who pay cash up to $ 99 a month. But this does not eliminate the concerns of lawyers.

"People die from the lack of access to drugs, which has been around for centuries, and I think it's undeniable," Lipskaya said.

Insulin manufacturers have told CBS News that they have taken steps to address price issues